Page last updated: 2024-08-25

oxazolidin-2-one and Communicable Diseases, Emerging

oxazolidin-2-one has been researched along with Communicable Diseases, Emerging in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beekmann, SE; Gilbert, DN; Polgreen, PM1
Broyles, J; Chow, S; Craig, AS; Devasia, RA; Jones, TF; Kainer, MA; Melton, K; Moore, KL; Schaffner, W; Simmons, BP1

Other Studies

2 other study(ies) available for oxazolidin-2-one and Communicable Diseases, Emerging

ArticleYear
Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey.
    Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Bacterial Infections; Communicable Diseases, Emerging; Data Collection; Drug Administration Schedule; Humans; Linezolid; Oxazolidinones; Practice Patterns, Physicians'; Societies, Medical; United States

2008
Response to emerging infection leading to outbreak of linezolid-resistant enterococci.
    Emerging infectious diseases, 2007, Volume: 13, Issue:7

    Topics: Acetamides; Anti-Infective Agents; Case-Control Studies; Colony Count, Microbial; Communicable Diseases, Emerging; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Length of Stay; Linezolid; Microbial Sensitivity Tests; Multivariate Analysis; Oxazolidinones; Vancomycin Resistance

2007